Dear Sir/Madam, Pursuant to Regulation 57(4) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find attached the intimation. Thanking You.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Prism Medico and Pharmacy Ltd has informed the stock exchanges (BSE and MSE) that it has not issued any non-convertible securities — such as non-convertible debentures or preference shares — for which any interest, dividend, or principal repayment is due during the quarter from 1 January 2026 to 31 March 2026. The filing is a mandatory quarterly compliance under SEBI's Listing Obligations and Disclosure Requirements Regulations. It is signed by Director Savender Singh (DIN: 09447213) and dated 31 December 2025. In plain terms, this is a 'nil' confirmation — the company has no such debt instruments on its books that would trigger payments next quarter.
No material impact on shareholders or the stock price — this is a routine regulatory disclosure confirming the absence of non-convertible securities requiring quarterly payments.